VIRGINAL RECURRENT GIGANTOMASTIA (BREAST HYPERTROPHY). A CASE REPORT

Authors

  • V. CHESHUK Bogomolets National Medical University, Kyiv, Ukraine
  • M. ANIKUSKO Kyiv City Clinical Oncology Center, Kyiv, Ukraine
  • V. KOZINA Kyiv City Clinical Oncology Center, Kyiv, Ukraine
  • V. ULISHCHENKO Bogomolets National Medical University, Kyiv, Ukraine
  • M. MALEC Kyiv City Clinical Oncology Center, Kyiv, Ukraine

DOI:

https://doi.org/10.15407/exp-oncology.2024.01.073

Keywords:

idiopathic gigantomastia, virginal recurrent gigantomastia, pseudoangiomatous stromal hyperplasia (PASH), endogenous hormone stimulation, reduction mammoplasty

Abstract

Virginal gigantomastia (VGM) is a benign disease of the breasts without a clearly established etiology. The treatment of VGM remains a problem. The conservative treatment is not effective while surgery is too traumatic. Most specialists recommend subcutaneous mastectomy with immediate implant reconstruction or reduction mammoplasty. The reduction mammoplasty with adjuvant hormone therapy is a variant of treatment of young patients with a risk of recurrence. We present a case of a patient with VGM who was operated in 2014. Reduction mammoplasty was performed. After 9 years, the patient had a relapse and second surgery, resection of the breasts with reduction mammoplasty. Tissues with cysts, fibrosis, hamartomas, and fibroadenomas were dissected. Histopathology revealed extensive fibrosis with hamartomas and fibroadenomas. The immunohistochemical examination of the breast tissue showed a high level (70%) of estrogen and progesterone receptors expression. We prescribed hormone therapy with tamoxifen 10 mg per day. Dynamic monitoring of the treatment result and control of the disease remission was carried out. Breast-conserving surgery performed in such patients can help alleviate the psychological, social, and physical disorders caused by VGM.

References

Vashistha A, Rundla M, Khan F, Om P. Idiopathic gigantomastia with pseudoangiomatous stromal hyperplasia: a case report. Int J Surg. Case Rep. 2020;77:915-919. https://doi.org/10.1016/j.ijscr.2020.09.151

Dancey A, Khan M, Dawson J, Peart F. Gigantomastia — a classification and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:493-502. https://doi.org/10.1016/j.bjps.2007.10.041

Wolfswinkel EM, Lemaine V, Weathers WM, et al. Hyperplastic breast anomalies in the female adolescent breast. Semin Plast Surg. 2013;27(1):49-55. https://doi.org/10.1055/s-0033-1347167

Sornlertlumvanich M, Rohitopakarn P, Samphao S, et al. Repeated recurrence of bilateral gigantomastia after subcutaneous mastectomy caused by tumoral pseudoangiomatous stromal hyperplasia: a case report and review of literature. BJR Case Rep. 2023;9(1):20220074. https://doi.org/10.1259/bjrcr.20220074

Hoppe IC, Patel PP, Singer-Granick CJ, Granick MS. Virginal mammary hypertrophy: a meta-analysis and treatment algorithm. Plast Reconst Surg. 2011;127(6):2224-2231. https://doi.org/10.1097/PRS.0b013e3182131bd1

Jean-Louis WF, Bowder A, Dupont CR, et al. Extreme gigantomastia caused by pseudoangiomatous stromal hyperplasia at Hopital Universitaire de Mirebalais: a case report. Plastic Reconst Surg Global Open. 2021;9(12):e3960. https://doi.org/10.1097/GOX.0000000000003960

Pokhrel B, Gautam S, Sharma S, Pokhrel NB, Bhatta NC, Rayamajhi S, Shrestha JM. Virginal breast hypertrophy in a 14-year-old girl: A case report. Clin Case Rep. 2020;9(1):198-202. https://doi.org/10.1002/ccr3.3498

Jabaiti S, Fayyad L, Isleem U. Prednisolone-induced virginal mammary hypertrophy: Case report. Int J Surg Case Rep. 2019;59:140-143. https://doi.org/10.1016/j.ijscr.2019.04.042

Szymańska E, Moszczyńska E, Polnik D, et al. Virginal breast hypertrophy in a patient with Beckwith — Wiedemann syndrome. Clin Case Rep. 2018;6(3):484-489. https://doi.org/10.1002/ccr3.1362

Das L, Rai A, Vaiphei K, Garg A, et al. Idiopathic gigantomastia: newer mechanistic insights implicating the paracrine milieu. Endocrine. 2019;66(2):166-177. https://doi.org/10.1007/s12020-019-02065-x

Kasielska-Trojan A, Pietrusiński M, Bugaj-Tobiasz M, et al. Genetic factors of idiopathic gigantomastia: clinical implications of aromatase and progesterone receptor polymorphisms. J Clin Med. 2022;11(3):642. https://doi.org/10.3390/jcm11030642

Nguyen NJ, Sanchez LM, Yassa M, et al. Idiopathic gigantomastia in a patient on polypharmacy. BJR Case Rep. 2021;7(5):20210052. https://doi.org/10.1259/bjrcr.20210052

Mareti E, Vatopoulou A, Spyropoulou GA, et al. Breast disorders in adolescence: a review of the literature. Breast Care (Basel). 2021;16(2):149-155. https://doi.org/10.1159/000511924

Patel K, Corcoran J. Breast reduction surgery in adolescents. Pediatr Ann. 2023;52(1):31-35. https://doi.org/10.3928/19382359-20221114-06

Hisham A, Abd Latib M, Basiron N. Juvenile breast hypertrophy: a successful breast reduction of 14.9% body weight without recurrence in a 5-year follow-up. Case Rep Surg. 2017;3491012. https://doi.org/10.1155/2017/3491012

Baker SB, Burkey BA, Thornton P, LaRossa D. Juvenile gigantomastia: presentation of four cases and review of the literature. Ann Plast Surg. 2001;46(5):517-525. https://doi.org/10.1097/00000637-200105000-00011

Benali S, Kouach J. Bilateral gestational gigantomastia. Pan Afr Med J. 2021;39:16. https://doi.org/10.11604/pamj.2021.39.16.29374

Zhou M, Jin M, Wang L, Pan LJ. Pregnancy-associated gigantomastia recurrence and ectopic breast after reduction mammaplasty: a case report. Cancer Biomark. 2017;20(2):225-229. https://doi.org/10.3233/CBM-160450

Saha S. Gestational gigantomastia with massively haemorrhagic ulcers. Postgrad Med J. 2022;98(1156):151-152. https://doi.org/10.1136/postgradmedj-2020-139159

Downloads

Published

31.05.2024

How to Cite

CHESHUK, V., ANIKUSKO, M., KOZINA, V., ULISHCHENKO, V., & MALEC, M. (2024). VIRGINAL RECURRENT GIGANTOMASTIA (BREAST HYPERTROPHY). A CASE REPORT. Experimental Oncology, 46(1), 73–76. https://doi.org/10.15407/exp-oncology.2024.01.073

Most read articles by the same author(s)